Gilead Sciences, Inc.’s Stock Price Soars to $70.67, Marking a Robust 3.18% Increase

Gilead Sciences, Inc. (GILD)

70.67 USD +2.18 (+3.18%) Volume: 31.21M

Boosted by a +3.18% surge this trading session, Gilead Sciences, Inc.’s stock price currently stands at 70.67 USD, attracting a robust trading volume of 31.21M. Despite the recent uptick, the stock has experienced a -12.76% change YTD, underlining the volatile nature of GILD stock performance.

Latest developments on Gilead Sciences, Inc.

Gilead Sciences, Inc. (NASDAQ:GILD) is experiencing a surge in stock price today following the success of their HIV prevention treatment, which showed 100% effectiveness in a Phase 3 trial. This news comes after the company celebrated Pride Month with Kite Pharma. Despite facing Wall Street speculation about obesity drugs, Gilead’s focus on liver treatments and the promising results of their HIV prevention shot have investors optimistic about the company’s future. Shareholders who invested a year ago may be in the red, but recent developments suggest a positive trend for Gilead Sciences.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma